ZA986904B - Process - Google Patents

Process

Info

Publication number
ZA986904B
ZA986904B ZA986904A ZA986904A ZA986904B ZA 986904 B ZA986904 B ZA 986904B ZA 986904 A ZA986904 A ZA 986904A ZA 986904 A ZA986904 A ZA 986904A ZA 986904 B ZA986904 B ZA 986904B
Authority
ZA
South Africa
Prior art keywords
füä1
ethylü
dibenzoäb
hydroxyethoxy
piperazinyl
Prior art date
Application number
ZA986904A
Other languages
English (en)
Inventor
Evan William Snape
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of ZA986904B publication Critical patent/ZA986904B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D281/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D281/02—Seven-membered rings
    • C07D281/04—Seven-membered rings having the hetero atoms in positions 1 and 4
    • C07D281/08—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D281/12—Seven-membered rings having the hetero atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D281/16—[b, f]-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Glass Compositions (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
  • Liquid Crystal Substances (AREA)
ZA986904A 1997-08-01 1998-07-31 Process ZA986904B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9716161.6A GB9716161D0 (en) 1997-08-01 1997-08-01 Process

Publications (1)

Publication Number Publication Date
ZA986904B true ZA986904B (en) 1999-02-01

Family

ID=10816746

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA986904A ZA986904B (en) 1997-08-01 1998-07-31 Process

Country Status (32)

Country Link
US (2) US6372734B1 (zh)
EP (2) EP1589008B1 (zh)
JP (2) JP2001512109A (zh)
KR (1) KR20010022241A (zh)
CN (1) CN1125058C (zh)
AT (2) ATE496037T1 (zh)
AU (1) AU739255B2 (zh)
BG (1) BG64796B1 (zh)
BR (1) BR9811061A (zh)
CA (1) CA2295792C (zh)
CY (2) CY2200162T2 (zh)
CZ (1) CZ299225B6 (zh)
DE (4) DE69841216D1 (zh)
EE (1) EE04550B1 (zh)
ES (2) ES2296568T3 (zh)
GB (2) GB9716161D0 (zh)
HK (2) HK1029992A1 (zh)
HU (1) HU228620B1 (zh)
ID (1) ID24219A (zh)
IL (1) IL133618A (zh)
MY (1) MY120999A (zh)
NO (1) NO20000484L (zh)
NZ (1) NZ501914A (zh)
PL (1) PL338384A1 (zh)
PT (2) PT1589008E (zh)
RU (1) RU2224754C2 (zh)
SI (2) SI1000043T1 (zh)
SK (1) SK287145B6 (zh)
TR (1) TR200000848T2 (zh)
TW (1) TW533207B (zh)
WO (1) WO1999006381A1 (zh)
ZA (1) ZA986904B (zh)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003235435A1 (en) * 2002-03-20 2003-10-08 Teva Pharmaceutical Industries Ltd. Crystalline forms of quetiapine hemifumarate
US7071331B2 (en) 2003-02-22 2006-07-04 Teva Pharmaceutical Industries Ltd. Synthesis of quetiapine and pharmaceutically acceptable salts thereof
WO2004078735A1 (en) * 2003-03-03 2004-09-16 Hetero Drugs Limited Novel polymorphs of quetiapine fumarate
US7053115B2 (en) * 2003-04-07 2006-05-30 Hetero Drugs Limited Crystalline form of dorzolamide hydrochloride
ES2223294B2 (es) 2003-08-08 2005-10-01 Vita Cientifica, S.L. Procedimiento de preparacion de un compuesto farmaceuticamente activo.
US20060081361A1 (en) * 2004-09-13 2006-04-20 Gabbey Lawrence W Oil cooler with integral filter
WO2006035293A1 (en) * 2004-09-27 2006-04-06 Ranbaxy Laboratories Limited Polymorphic forms of quetiapine hemifumarate
WO2006056772A2 (en) * 2004-11-23 2006-06-01 Pliva Hrvatska D.O.O. Salts of quetiapine
GB0425729D0 (en) * 2004-11-23 2004-12-22 Pliva Res & Dev Ltd Heterocyclic compounds
ES2234447B1 (es) * 2005-03-07 2006-03-01 Union Quimico-Farmaceutica S.A. Procedimiento para la obtencion de un derivado de 11-(4-sustituido-1-piperazinil)dibenzo(b,f)(1,4)tiazepina.
WO2006113425A1 (en) 2005-04-14 2006-10-26 Teva Pharmaceutical Industries Ltd. Process for preparing quetiapine fumarate
US20070072840A1 (en) * 2005-05-30 2007-03-29 Pandya Bhargav Polymorphic forms of quetiapine
EP1928849A1 (en) * 2005-09-30 2008-06-11 Fermion Oy New crystallization process of quetiapine hemifumarate
EP1948628A1 (en) * 2005-10-28 2008-07-30 Fermion Oy Quetiapine hemifumarate purification by crystallization
CN101360503A (zh) * 2005-11-18 2009-02-04 阿斯利康公司 液体制剂
US8389510B2 (en) * 2005-11-18 2013-03-05 Astrazeneca Ab Crystalline forms
EP1951257A4 (en) * 2005-11-18 2008-11-05 Astrazeneca Ab CRYSTALLINE FORMS
US20090069291A1 (en) * 2005-11-18 2009-03-12 Astrazeneca Ab Salt Forms
CN101360725B (zh) * 2005-11-18 2011-09-21 阿斯利康公司 固体制剂
CZ300451B6 (cs) * 2006-07-03 2009-05-20 Farmak, A. S. Zpusob prípravy solí 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanolu (quetiapinu) a jejich cištení
WO2008066620A2 (en) * 2006-10-20 2008-06-05 Concert Pharmaceuticals Inc. Dibenzothiazepine derivatives
PT1958617E (pt) 2007-02-14 2010-10-28 Lesvi Laboratorios Sl Composições farmacêuticas contendo fumarato de quetiapina
WO2008121415A2 (en) * 2007-03-29 2008-10-09 Teva Pharmaceutical Industries Ltd. Improved process for preparing quetiapine fumarate
US8101597B2 (en) * 2007-05-07 2012-01-24 Actavis Group Ptc Ehf Quetiapine salts and their polymorphs
US20090082334A1 (en) * 2007-09-25 2009-03-26 Protia, Llc Deuterium-enriched quetiapine
AU2008333226B2 (en) * 2007-12-05 2013-02-07 Janssen Pharmaceutica Nv Dibenzoazepine and dibenzooxazepine TRPA1 agonists
SI2262486T1 (sl) 2008-08-01 2013-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Sestavek kvetiapina
US20100069356A1 (en) * 2008-09-17 2010-03-18 Auspex Pharmaceuticals, Inc. Dibenzothiazepine modulators of dopamine, alpha adrenergic, and serotonin receptors
JP2012519683A (ja) 2009-03-04 2012-08-30 ランバクシー ラボラトリーズ リミテッド フマル酸クエチアピンの調製方法
DK2742152T3 (en) 2011-08-12 2017-07-31 Qiagen Gmbh PROCEDURE FOR ISOLATING NUCLEIC ACIDS

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE787249A (fr) 1971-08-05 1973-02-05 Squibb & Sons Inc Derives amino d'acides pyrazolopyridine carboxyliques, leurs esters et les sels de ces composes, ainsi que leurs procedes de preparation
GB8607684D0 (en) * 1986-03-27 1986-04-30 Ici America Inc Thiazepine compounds
GB8705574D0 (en) * 1987-03-10 1987-04-15 Ici Plc Preparation of thiazepine compound

Also Published As

Publication number Publication date
ES2296568T3 (es) 2011-05-06
CN1265101A (zh) 2000-08-30
WO1999006381A1 (en) 1999-02-11
TR200000848T2 (tr) 2000-08-21
CN1125058C (zh) 2003-10-22
DE98936529T1 (de) 2008-11-20
CY2200161T2 (el) 2010-07-28
NO20000484D0 (no) 2000-01-31
GB9814882D0 (en) 1998-09-09
HK1029992A1 (en) 2001-04-20
TW533207B (en) 2003-05-21
AU8549898A (en) 1999-02-22
EE04550B1 (et) 2005-10-17
PT1000043E (pt) 2009-11-30
MY120999A (en) 2005-12-30
US6372734B1 (en) 2002-04-16
EP1000043A1 (en) 2000-05-17
ES2296568T1 (es) 2008-05-01
RU2224754C2 (ru) 2004-02-27
HU228620B1 (en) 2013-04-29
ES2296575T3 (es) 2010-02-05
DE69842104D1 (de) 2011-03-03
HK1081962A1 (en) 2006-05-26
EP1589008B1 (en) 2011-01-19
HUP0002663A3 (en) 2001-10-29
CZ299225B6 (cs) 2008-05-21
AU739255B2 (en) 2001-10-04
SK287145B6 (sk) 2010-01-07
KR20010022241A (ko) 2001-03-15
DE69841216D1 (de) 2009-11-19
EP1589008A1 (en) 2005-10-26
CA2295792A1 (en) 1999-02-11
CY2200162T2 (el) 2010-07-28
BG64796B1 (bg) 2006-04-28
BG104176A (en) 2000-08-31
PT1589008E (pt) 2011-03-23
JP2001512109A (ja) 2001-08-21
SK1302000A3 (en) 2000-06-12
CA2295792C (en) 2007-04-17
SI1589008T1 (sl) 2011-04-29
PL338384A1 (en) 2000-10-23
JP2009102345A (ja) 2009-05-14
ID24219A (id) 2000-07-13
SI1000043T1 (sl) 2010-01-29
BR9811061A (pt) 2000-09-19
HUP0002663A2 (hu) 2001-09-28
DE05011169T1 (de) 2008-11-06
ATE496037T1 (de) 2011-02-15
IL133618A (en) 2004-02-08
IL133618A0 (en) 2001-04-30
NO20000484L (no) 2000-03-16
US20020147186A1 (en) 2002-10-10
CZ2000341A3 (cs) 2000-05-17
EE200000062A (et) 2000-10-16
NZ501914A (en) 2001-09-28
ATE444959T1 (de) 2009-10-15
EP1000043B1 (en) 2009-10-07
GB9716161D0 (en) 1997-10-08
ES2296575T1 (es) 2008-05-01

Similar Documents

Publication Publication Date Title
GB9814882D0 (en) Process
YU49312B (sh) Kristalni hidratni derivati 3,4,4-trisupstituisanih - peperidinil-n-alkilkarboksilata, njihovi intermedijari i postupak za dobijanje
NZ333586A (en) Anticonvulsant sulfamate derivatives, preferably topiramate, useful in treating obesity
BG106786A (en) Process for the preparation of amorphous atorvastatin
HUT74604A (en) Process for the preparation of concentrated, biologically active silicon compounds
HU9903899D0 (en) Process for producing l-amino acids by fermentation
HU9904315D0 (en) Process for preparing orthoesters
AU8453691A (en) A process for treating animal hairs by means of solubilization
AU1783795A (en) Improved, large-scale process for azapirone synthesis
IL118210A0 (en) Process for the preparation of substituted oxazolidinone compounds useful as herbicides
IL97672A0 (en) Process for producing d-isocitric acid by fermentation
IE891895L (en) 2-amino-7-hydroxytetraline ethers
EP0974591A4 (en) CRYSTALLINE FUMARATES OF 2-PHENYL-1,3-THIAZOLIDIN-4-ON DERIVATIVES
GR1003358B (el) Διαδικασια παραγωγης 1,2-διμεθυλ-3-υδροξυπυριδ-4-ονης
AU3281397A (en) Process for the preparation of organic salts of n'n-diacetylcystine
CA2174506A1 (en) Process for Preparing 3,4-Diaryl-5-Isoxazolyl Acetic Acid Derivatives
MY124079A (en) Process for producing 1, 2-dimethyl-3-hydroxypyrid-4- one
AU2381595A (en) Process for desalinating water while producing power
HU906336D0 (en) Process for producing biocide preparatives
HU207272B (en) Process for environment-protecting working up fermentative rest of lysine production